Alan W. Tamarelli
About Alan
Alan’s practice focuses on the representation of biotech, pharma, medical device and other life sciences companies in connection with technology-driven strategic transactions. He advises companies on research collaborations and development agreements, intellectual property and technology licensing agreements, and commercial collaborations, including joint ventures, profit-sharing arrangements and co-promotion agreements. He also has experience with manufacturing, distribution, supply and quality agreements, clinical trial agreements, M&A transactions, and life sciences industry-specific matters and counseling.
Experience
-
Phrontline Announces Global Strategic Partnership With Samsung Bioepis
-
Tourmaline Bio Enters Into Agreement to be Acquired by Novartis
-
Hengrui Pharma and Braveheart Bio Enter Into Exclusive License Agreement
-
Hengrui Pharma and GSK Enter Agreement to Develop up to 12 Medicines
-
Somite AI Announces $47 Million Series A
Admissions and credentials
- Massachusetts
- New York
- Pennsylvania
Rankings and accolades
Legal 500 US: Recommended for Commercial Deals and Contracts (2018)
Legal 500 US: Recommended for Technology Transactions (2018)
Get In Touch
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.